The EU Commission approves the acquisition of a leading global R&D crop protection company by a leading global generic crop protection company, subject to remedies (ChemChina / Syngenta)

ChemChina/Syngenta: when growth is no longer organic* In a nutshell: This case concerned the acquisition of Syngenta by ChemChina, which already controlled Adama, the largest supplier of generic crop protection products. Adama is the largest generic company in this industry worldwide and in Europe. Though it has a different profile than R&D firms like Syngenta, it competes with Syngenta in off-patent crop protection products in many areas and geographical markets. The Commission carried out a thorough assessment of all these overlaps and found that more than one hundred of them raised competition problems, because of a lack of remaining alternatives and close competition between Adama and Syngenta. The comprehensive set of remedies proposed by the parties eliminated all concerns

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Laura Seritti, Jullien Sylvestre, The EU Commission approves the acquisition of a leading global R&D crop protection company by a leading global generic crop protection company, subject to remedies (ChemChina / Syngenta), 5 April 2017, e-Competitions Merger Remedies, Art. N° 86504

Visites 187

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues